Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v5-EN
Language English English
Date Updated 2020-03-24 2020-03-09
Drug Identification Number 02329743 02329743
Brand name DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC
Common or Proper name Sodium Iodide 131 I Sodium Iodide 131 I
Company Name JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
Ingredients SODIUM IODIDE 131 I SODIUM IODIDE 131 I
Strength(s) 7400MBq 7400MBq
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 1 Capsule/Vial 1 Capsule/Vial
ATC code V10XA V10XA
ATC description
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-02-24 2020-02-24
Estimated end date 2020-03-23 2020-03-23
Actual end date 2020-03-23
Shortage status Resolved Actual shortage
Company comments A product component procured from a 3rd party did not meet JDI’s specifications. A product component procured from a 3rd party did not meet JDI’s specifications.
Health Canada comments